美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Alpha Tau Medical Warrant

1.17

-0.0400-3.31%

成交量：1,048.00

成交额：1,226.78

市值：8,234.53万

市盈率：-2.24

高：1.17

开：1.17

低：1.17

收：1.21

52周最高：1.50

52周最低：0.1300

股本：7,038.06万

流通股本：7,038.06万

量比：0.30

换手率：0.00%

股息：- -

股息率：- -

每股收益(TTM):-0.5213

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

Alpha Tau Medical将在ASCO GI 2026研讨会上公布两项新积极成果展示蒙特利尔胰腺癌Alpha Dart®研究的免疫保护与高疾病控制率

Alpha Tau向FDA提交Alpha Dart®治疗复发性皮肤鳞状细胞癌的首个上市前审批模块

Alpha Tau获得FDA批准启动局部复发前列腺癌患者试验

Alpha Tau Medical成功治疗美国多中心胰腺癌临床试验首例患者

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/DRTSW/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DRTSW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DRTSW\",,,,,undefined,":{"symbol":"DRTSW","market":"US","secType":"STK","nameCN":"Alpha Tau Medical Warrant","latestPrice":1.17,"timestamp":1772462976525,"preClose":1.21,"halted":0,"volume":1048,"delay":0,"changeRate":-0.03305785123966945,"floatShares":70380571,"shares":70380571,"eps":-0.5213,"marketStatus":"交易中","change":-0.04,"latestTime":"03-02 10:02:25 EST","open":1.17,"high":1.17,"low":1.17,"amount":1226.7763288,"amplitude":0,"askPrice":1.24,"askSize":100,"bidPrice":1.2,"bidSize":173,"shortable":0,"etf":0,"ttmEps":-0.5213,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772485200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.21,"volumeRatio":0.296021},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DRTSW\",,,,,undefined,":{"symbol":"DRTSW","floatShares":70380571,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.296021,"shares":70380571,"dividePrice":0,"high":1.17,"amplitude":0,"preClose":1.21,"low":1.17,"week52Low":0.13,"pbRate":"--","week52High":1.5,"institutionHeld":0,"latestPrice":1.17,"committee":0.267399,"eps":-0.5213,"divideRate":0,"volume":1048,"delay":0,"ttmEps":-0.5213,"open":1.17,"prevYearClose":0.34,"prevWeekClose":1.21,"prevMonthClose":1.21,"prevQuarterClose":0.34,"fiveDayClose":1.17,"twentyDayClose":0.906,"sixtyDayClose":0.32},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DRTSW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DRTSW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DRTSW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DRTSW\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1152568891","title":"Alpha Tau Medical将在ASCO GI 2026研讨会上公布两项新积极成果 展示蒙特利尔胰腺癌Alpha Dart®研究的免疫保护与高疾病控制率","url":"https://stock-news.laohu8.com/highlight/detail?id=1152568891","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152568891?lang=zh_cn&edition=fundamental","pubTime":"2026-01-06 22:08","pubTimestamp":1767708521,"startTime":"0","endTime":"0","summary":"Alpha Tau Medical宣布，其即将在ASCO GI 2026研讨会上展示的两项研究取得了新的积极结果。这些成果重点揭示了Alpha Dart®蒙特利尔胰腺癌研究中体现的免疫保护特性与卓越疾病控制效果。\n研究数据显示，该疗法在维持患者免疫系统功能的同时，实现了较高的疾病控制水平。这一突破为胰腺癌治疗领域提供了新的方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRTS","BK4082","DRTSW"],"gpt_icon":0},{"id":"1128236953","title":"Alpha Tau向FDA提交Alpha Dart®治疗复发性皮肤鳞状细胞癌的首个上市前审批模块","url":"https://stock-news.laohu8.com/highlight/detail?id=1128236953","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128236953?lang=zh_cn&edition=fundamental","pubTime":"2026-01-05 22:06","pubTimestamp":1767622002,"startTime":"0","endTime":"0","summary":"Alpha Tau Medical已向美国食品药品监督管理局（FDA）提交了Alpha Dart®治疗复发性皮肤鳞状细胞癌（cSCC）的首个上市前审批模块。这一重要进展标志着该创新疗法在监管审批流程中迈出了关键一步。\nAlpha Dart®作为一种新型放射治疗技术，专注于为复发型皮肤鳞状细胞癌患者提供精准靶向治疗。此次提交的模块涵盖了产品的核心数据，为后续审批奠定了坚实基础。\n该公司的突破性技术平台通过α粒子放射疗法直接作用于肿瘤细胞，在早期临床研究中展现出显著疗效。此次监管里程碑将加速该疗法为患者提供创新治疗选择的进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRTSW","BK4082","DRTS"],"gpt_icon":0},{"id":"1160292703","title":"Alpha Tau获得FDA批准启动局部复发前列腺癌患者试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1160292703","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160292703?lang=zh_cn&edition=fundamental","pubTime":"2025-12-02 22:02","pubTimestamp":1764684124,"startTime":"0","endTime":"0","summary":"Alpha Tau获得FDA批准，启动针对局部复发前列腺癌患者的临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","DRTSW","DRTS"],"gpt_icon":0},{"id":"1151041494","title":"Alpha Tau Medical成功治疗美国多中心胰腺癌临床试验首例患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1151041494","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151041494?lang=zh_cn&edition=fundamental","pubTime":"2025-09-02 20:31","pubTimestamp":1756816268,"startTime":"0","endTime":"0","summary":"Alpha Tau Medical成功治疗美国多中心胰腺癌临床试验首例患者","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRTSW","BK4082","DRTS"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}]}}